TWOEquity · Weekly research terminal

7762

PET PHARM BIO

TW Healthcare Drug Manufacturers - General

Latest week
14 Aug 2026
Weekly close
50.90 TWD
Fair value
53.53 TWD
Next-week expectancy
Undecided 45.18%
Crowd view
Current verdict No votes yet Be first to vote

Sharemaestro
Weekly Chart Pack Completed weekly market data · Independent research

TWO · Equity · Taiwan

7762

PET PHARM BIO

Healthcare Drug Manufacturers - General

Pet Pharm Biotech Co., Ltd. manufactures and sells pharmaceutical products. The company also engages in the research, development, and production of nuclear medicine drugs. Its products include FDG fluodeoxyglucose, naolixi, and sodium fluoride injections; and radioactive sodium iodide capsules. The company was founded in 2011 and is based in New Taipei City, Taiwan.

Last updated
14 Aug 2026
Exchange
Taipei Exchange · TWO
Sector
Healthcare
Industry
Drug Manufacturers - General
Currency
TWD
Market capitalisation
2,974,284,544
Fair value reference
53.53
Next-week expectancy
Undecided · 45.18%

Over the latest 12 completed weeks ending 2026-08-14, 7762 fell 3.84%, moving from 52.93 to 50.90. The latest weekly close is below the Trend Line and below Fair Value. Trend Signal is inactive on the latest week and was active in 0 of the last 12 weeks. Relative Strength is -43.24 and has improved across the 12-week window. Market Dynamics is 0.22 on the latest week. Next-week expectancy is undecided at 45.18% based on similar historical setup states.

Week Ending
14 Aug 2026
Latest Close
50.90
12-Week Change
-3.84%
Trend Signal
Inactive
Next-Week Expectancy
Undecided 45.18%
Signal Weeks
0 of 12

Weekly Price

Weekly Close Trend Line Fair Value Activity Lines

Chart Panels

Choose up to 5 panels. Drag panel headers to reorder.

Chart Summary

Key Points

Week Ending
14 Aug 2026
Latest Close
50.90
12-Week Change
-3.84%
Trend Signal
Inactive
Next-Week Expectancy
Undecided 45.18%
Signal Weeks
0 of 12
Vs Trend Line
Below
Vs Fair Value
Below
Relative Strength
-43.24
Market Dynamics
0.22

Over the latest 12 completed weeks ending 2026-08-14, 7762 fell 3.84%, moving from 52.93 to 50.90. The latest weekly close is below the Trend Line and below Fair Value. Trend Signal is inactive on the latest week and was active in 0 of the last 12 weeks. Relative Strength is -43.24 and has improved across the 12-week window. Market Dynamics is 0.22 on the latest week. Next-week expectancy is undecided at 45.18% based on similar historical setup states.

Industry Peers

Taiwan equities in Drug Manufacturers - General

Stock Exchange Week Open High Low Close Change
6130 Shangya Technology Co., Ltd. TWO 14 Aug 2026 24.70 30.50 24.70 29.00 17.41%
4102 Yung Zip Chemical Ind. Co., Ltd. TWO 14 Aug 2026 19.05 19.15 18.50 19.10 0.26%

Next-week expectancy

Next-week expectancy is a short-term historical read. It compares the latest completed-week setup with broadly similar past setups and asks whether the following week tended to close higher or lower.

It is not a trend call, a price target, or a guarantee. A positive read can appear while price is below trend or activity pressure is weak, because it is measuring short-term follow-through odds for the current setup state.

Use it as one context layer beside Trend Line, Relative Strength, Market Dynamics, Fair Value, and the visible price structure.

Evidence context